157 related articles for article (PubMed ID: 9112901)
1. Endothelin-1 is a mediator of intimal hyperplasia in organ culture of human saphenous vein.
Masood I; Porter KE; London NJ
Br J Surg; 1997 Apr; 84(4):499-503. PubMed ID: 9112901
[TBL] [Abstract][Full Text] [Related]
2. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
[TBL] [Abstract][Full Text] [Related]
3. Vascular-wall remodeling of 3 human bypass vessels: organ culture and smooth muscle cell properties.
Mekontso-Dessap A; Kirsch M; Guignambert C; Zadigue P; Adnot S; Loisance D; Eddahibi S
J Thorac Cardiovasc Surg; 2006 Mar; 131(3):651-8. PubMed ID: 16515919
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel treatment reduces neointimal hyperplasia in cultured human saphenous veins.
Schachner T; Steger C; Heiss S; Bonaros N; Sterlacci W; Laufer G; Bonatti J
Eur J Cardiothorac Surg; 2007 Dec; 32(6):906-11. PubMed ID: 17923411
[TBL] [Abstract][Full Text] [Related]
5. ETA receptor antagonists inhibit intimal smooth muscle cell proliferation in human vessels.
Maguire JJ; Yu JC; Davenport AP
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():184S-188S. PubMed ID: 12193082
[TBL] [Abstract][Full Text] [Related]
6. Increased connexin43 expression in human saphenous veins in culture is associated with intimal hyperplasia.
Déglise S; Martin D; Probst H; Saucy F; Hayoz D; Waeber G; Nicod P; Ris HB; Corpataux JM; Haefliger JA
J Vasc Surg; 2005 Jun; 41(6):1043-52. PubMed ID: 15944608
[TBL] [Abstract][Full Text] [Related]
7. Production and inhibition of the gelatinolytic matrix metalloproteinases in a human model of vein graft stenosis.
Porter KE; Thompson MM; Loftus IM; McDermott E; Jones L; Crowther M; Bell PR; London NJ
Eur J Vasc Endovasc Surg; 1999 May; 17(5):404-12. PubMed ID: 10329524
[TBL] [Abstract][Full Text] [Related]
8. A Gbetagamma inhibitor reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Petrofski JA; Hata JA; Williams ML; Parsa CJ; Thompson RB; Hanish SI; Gehrig TR; Koch WJ; Milano CA
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1683-90. PubMed ID: 16308016
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-B receptors mediate intimal hyperplasia in an organ culture of human saphenous vein.
Porter KE; Olojugba DH; Masood I; Pemberton M; Bell PR; London NJ
J Vasc Surg; 1998 Oct; 28(4):695-701. PubMed ID: 9786266
[TBL] [Abstract][Full Text] [Related]
10. Human venous endothelium can promote intimal hyperplasia in a paracrine manner.
Allen KE; Varty K; Jones L; Sayers RD; Bell PR; London NJ
J Vasc Surg; 1994 Apr; 19(4):577-84. PubMed ID: 8164272
[TBL] [Abstract][Full Text] [Related]
11. The development of an in vitro flow model of human saphenous vein graft intimal hyperplasia.
Porter KE; Nydahl S; Dunlop P; Varty K; Thrush AJ; London NJ
Cardiovasc Res; 1996 Apr; 31(4):607-14. PubMed ID: 8689653
[TBL] [Abstract][Full Text] [Related]
12. Intimal proliferation in an organ culture of human saphenous vein.
Soyombo AA; Angelini GD; Bryan AJ; Jasani B; Newby AC
Am J Pathol; 1990 Dec; 137(6):1401-10. PubMed ID: 2260628
[TBL] [Abstract][Full Text] [Related]
13. The endothelin 1A receptor antagonist BSF 302146 is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts.
Wan S; Yim AP; Johnson JL; Shukla N; Angelini GD; Smith FC; Dashwood MR; Jeremy JY
J Thorac Cardiovasc Surg; 2004 May; 127(5):1317-22. PubMed ID: 15115988
[TBL] [Abstract][Full Text] [Related]
14. Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo.
Schepers A; Eefting D; Bonta PI; Grimbergen JM; de Vries MR; van Weel V; de Vries CJ; Egashira K; van Bockel JH; Quax PH
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2063-9. PubMed ID: 16825596
[TBL] [Abstract][Full Text] [Related]
15. Influence of angioscopic vein graft preparation on development of neointimal hyperplasia in an organ culture model of human saphenous vein.
Wilson YG; Davies AH; Southgate K; Currie IC; Knight D; Patton D; Baird RN; Lamont PM; Angelini GD
J Endovasc Surg; 1996 Nov; 3(4):436-44. PubMed ID: 8959504
[TBL] [Abstract][Full Text] [Related]
16. The effects of endothelin-1 on collagen type I and type III synthesis in cultured porcine coronary artery vascular smooth muscle cells.
Rizvi MA; Katwa L; Spadone DP; Myers PR
J Mol Cell Cardiol; 1996 Feb; 28(2):243-52. PubMed ID: 8729057
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthase gene transfer inhibits biological features of bypass graft disease in the human saphenous vein.
Tanner FC; Largiadèr T; Greutert H; Yang Z; Lüscher TF
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):20-6. PubMed ID: 14752408
[TBL] [Abstract][Full Text] [Related]
18. Endothelin-1 and vein graft occlusion in patients undergoing bypass surgery.
Dashwood MR
Eur J Clin Invest; 2009 Jun; 39 Suppl 2():78-87. PubMed ID: 19335750
[TBL] [Abstract][Full Text] [Related]
19. Validation of an in vitro model of human saphenous vein hyperplasia.
Castronuovo JJ; Smith TJ; Price RM
J Vasc Surg; 2002 Jan; 35(1):152-7. PubMed ID: 11802147
[TBL] [Abstract][Full Text] [Related]
20. Statins for the prevention of vein graft stenosis: a role for inhibition of matrix metalloproteinase-9.
Porter KE; Turner NA
Biochem Soc Trans; 2002 Apr; 30(2):120-6. PubMed ID: 12023838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
